Rosemary Harrison serves as Executive at Trillium Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Rosemary Harrison has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 17, 2021 involved selling 75 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 17, 2021 | TRIL | $0 | Disposition | 75 | $N/A | Discretionary |
Rosemary Harrison currently holds 0 shares of Trillium Therapeutics Inc. (TRIL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rosemary Harrison has been a net neutral trader of TRIL stock. They have purchased $0 and sold $0 worth of shares.
Rosemary Harrison's most recent insider trade was on Nov 17, 2021, when they sold 75 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted